Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Raw Materials (2016 - 2021)

Historic Raw Materials for AtriCure (ATRC) over the last 13 years, with Q2 2021 value amounting to $12.4 million.

  • AtriCure's Raw Materials fell 305.38% to $12.4 million in Q2 2021 from the same period last year, while for Jun 2021 it was $12.4 million, marking a year-over-year decrease of 305.38%. This contributed to the annual value of $12.0 million for FY2020, which is 754.99% up from last year.
  • Latest data reveals that AtriCure reported Raw Materials of $12.4 million as of Q2 2021, which was down 305.38% from $11.3 million recorded in Q1 2021.
  • AtriCure's Raw Materials' 5-year high stood at $12.8 million during Q2 2020, with a 5-year trough of $5.8 million in Q2 2017.
  • Its 5-year average for Raw Materials is $9.7 million, with a median of $10.0 million in 2019.
  • In the last 5 years, AtriCure's Raw Materials tumbled by 492.94% in 2017 and then soared by 5018.93% in 2018.
  • AtriCure's Raw Materials (Quarter) stood at $7.8 million in 2017, then increased by 17.34% to $9.1 million in 2018, then rose by 22.26% to $11.1 million in 2019, then rose by 7.55% to $12.0 million in 2020, then grew by 3.47% to $12.4 million in 2021.
  • Its Raw Materials stands at $12.4 million for Q2 2021, versus $11.3 million for Q1 2021 and $12.0 million for Q4 2020.